AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (7.7 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese | Open Access

Preparation and efficacy evaluation of anti-M blood group antibodies based on specific agglutination screening and molecular modeling

Yuchun Hou1,2, Yating Ling3, Yu Zhang3, Xinxia Chang2, Jinglei Xu2, Chengtao He3, Qiang Fu3, Buqiang Wang4, Fangfang Chen4, Qian Zhang2 ( ), Xiaoming Wang1,2 ( )
Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166
National Health Commission Key Laboratory of Antibody Techniques, School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166
Key Laboratory of Transfusion Medicine, Nanjing Red Cross Blood Center, Nanjing 210003
Jiangsu Libo Medicine Biotechnology Co., Ltd., Jiangyin 214437, China
Show Author Information

Abstract

Objective

To establish a strategy combining specific erythrocyte agglutination screening with molecular modeling for the efficient preparation of anti-M blood group antibodies, and to verify their clinical detection efficacy.

Methods

An agglutination screening strategy targeting intact erythrocytes was adopted, combined with flow cytometry sorting to obtain anti-M specific B cells for B cell receptor (BCR) sequencing. Evolutionary biological analysis was performed on the antibody variable region sequences, and molecular modeling was integrated to predict antigen-antibody binding affinity. Candidate sequences were screened to construct expression plasmids, and recombinant antibodies were expressed in a eukaryotic system. Erythrocyte agglutination test, titer determination and flow cytometry were used to verify antibody binding specificity, and erythrocyte samples with different MN phenotypes were employed to evaluate its blood group identification efficacy.

Results

From the blood sample with an anti-M antibody titer of 1∶512, 96 anti-M specific B cells were obtained via specific agglutination screening, and 28 pairs of heavy and light chain variable region sequences were acquired through BCR sequencing. Six candidate antibodies were screened for expression and verification based on evolutionary biological analysis and molecular modeling, among which 2G9, 2F11, and 2H5 could specifically agglutinate M antigen-positive erythrocytes, with 2G9 showing the highest agglutination titer (1∶256). Flow cytometry confirmed that2G9 could specifically recognize the M antigen, and this antibody achieved a 100% detection rate and 0% false positive rate for M blood group in erythrocytes with different MN phenotypes.

Conclusion

The anti-M blood group antibody 2G9 prepared in this study has excellent clinical testing efficacy and can be used for clinical M blood group identification. The specific agglutination screening of red blood cells combined with molecular modeling strategies provides a new method for the preparation of blood group antibodies.

CLC number: R446.6 Document code: A Article ID: 1007-4368(2026)11-1649-10

References

【1】
【1】
 
 
Journal of Nanjing Medical University (Natural Sciences)
Pages 1649-1658

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Hou Y, Ling Y, Zhang Y, et al. Preparation and efficacy evaluation of anti-M blood group antibodies based on specific agglutination screening and molecular modeling. Journal of Nanjing Medical University (Natural Sciences), 2026, 46(11): 1649-1658. https://doi.org/10.7655/NYDXBNSN260416

6

Views

0

Downloads

0

Crossref

Received: 03 April 2026
Revised: 20 May 2026
Accepted: 30 May 2026
Published: 15 November 2026
© 2026 Editorial Board of Journal of Nanjing Medical University(Natural Sciences)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).